{"id":3425,"date":"2018-12-04T04:15:28","date_gmt":"2018-12-03T18:15:28","guid":{"rendered":"https:\/\/doseme-rx.com\/?p=3425"},"modified":"2021-04-06T15:46:18","modified_gmt":"2021-04-06T05:46:18","slug":"doseme-tabula-rasa-healthcare","status":"publish","type":"post","link":"https:\/\/doseme-rx.com\/fr\/news-media\/articles\/doseme-tabula-rasa-healthcare","title":{"rendered":"Tabula Rasa HealthCare to Acquire DoseMe"},"content":{"rendered":"

DoseMe, the first company in the world to design a precision dosing platform – DoseMeRx – specifically developed for clinical practice today announced it will be acquired by Tabula Rasa HealthCare, Inc<\/a> (NASDAQ:TRHC) a healthcare technology company advancing the field of medication safety.<\/p>\n

Tabula Rasa HealthCare (\u201cTRHC\u201d) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. TRHC provides solutions for a range of payers, providers and other healthcare organizations<\/p>\n

\u201cTRHC is the leader in medication risk management and the opportunity for us to leverage that expertise and bring together the science and technology of our two organizations is very impactful for providers and patients around the world,\u201d said Charles Cornish, CEO, DoseMe.<\/p>\n

\u201cWith DoseMe\u2019s state-of-the-art decision support tool combined with our ability to predict and prevent harmful drug interactions through tools such as the MRM Matrix\u00ae, we are now able to offer hospitals a broader range of protection against adverse drug events, the fourth leading cause of death in the US,\u201d said TRHC Chairman and CEO, Calvin H. Knowlton, Ph.D. \u201cTogether, we can power the shift to precision prescribing, tailoring medication to meet individual needs and tolerances, which will have a profound impact on safety, quality, and costs, such as medication-related increased hospital length-of-stay.\u201d<\/p>\n

To view the full press release\u00a0visit TRHC latest news<\/a><\/p>\n

About DoseMeRx<\/strong><\/p>\n

DoseMeRx is a precision dosing software designed for healthcare practitioners that uses Bayesian dosing methods to predict the optimal dose of drugs monitored by Therapeutic Drug Monitoring. It is unique support software that leverages clinically validated pharmacokinetic drug models, patient characteristics, genotype (if available) and exact patient responses to the drug dosed (via drug concentrations) to guide dose optimization. Its simplicity and portability means Bayesian dosing benefits can be brought to every bedside. Try the full DoseMeRx platform including all drug packages free for 14 days.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

DoseMe, the first company in the world to design a precision dosing platform – DoseMeRx – specifically developed for clinical practice today announced it will be acquired by Tabula Rasa HealthCare, Inc (NASDAQ:TRHC) a healthcare technology company advancing the field of medication safety. Tabula Rasa HealthCare (\u201cTRHC\u201d) is a leader in providing patient-specific, data-driven technology […]<\/p>\n","protected":false},"author":4,"featured_media":7998,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[8],"tags":[35],"article-type":[49],"class_list":["post-3425","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-media","tag-company-announcement"],"acf":[],"yoast_head":"\nTabula Rasa HealthCare To Aquire DoseMe<\/title>\n<meta name=\"description\" content=\"DoseMe, the first company in the world to design a precision dosing platform - DoseMeRx - specifically developed for clinical practice today announced it will be acquired by Tabula Rasa HealthCare, Inc (NASDAQ:TRHC) a healthcare technology company advancing the field of medication safety.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/doseme-rx.com\/fr\/news-media\/articles\/doseme-tabula-rasa-healthcare\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tabula Rasa HealthCare To Aquire DoseMe\" \/>\n<meta property=\"og:description\" content=\"DoseMe, the first company in the world to design a precision dosing platform - DoseMeRx - specifically developed for clinical practice today announced it will be acquired by Tabula Rasa HealthCare, Inc (NASDAQ:TRHC) a healthcare technology company advancing the field of medication safety.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/doseme-rx.com\/fr\/news-media\/articles\/doseme-tabula-rasa-healthcare\" \/>\n<meta property=\"og:site_name\" content=\"DoseMeRx\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DoseMeApp\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-12-03T18:15:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-04-06T05:46:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/doseme-rx.com\/wp-content\/uploads\/2018\/12\/News-Article-Banners.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1120\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Nicola Hunter\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DoseMeApp\" \/>\n<meta name=\"twitter:site\" content=\"@DoseMeApp\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nicola Hunter\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tabula Rasa HealthCare To Aquire DoseMe","description":"DoseMe, the first company in the world to design a precision dosing platform - DoseMeRx - specifically developed for clinical practice today announced it will be acquired by Tabula Rasa HealthCare, Inc (NASDAQ:TRHC) a healthcare technology company advancing the field of medication safety.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/doseme-rx.com\/fr\/news-media\/articles\/doseme-tabula-rasa-healthcare","og_locale":"fr_FR","og_type":"article","og_title":"Tabula Rasa HealthCare To Aquire DoseMe","og_description":"DoseMe, the first company in the world to design a precision dosing platform - DoseMeRx - specifically developed for clinical practice today announced it will be acquired by Tabula Rasa HealthCare, Inc (NASDAQ:TRHC) a healthcare technology company advancing the field of medication safety.","og_url":"https:\/\/doseme-rx.com\/fr\/news-media\/articles\/doseme-tabula-rasa-healthcare","og_site_name":"DoseMeRx","article_publisher":"https:\/\/www.facebook.com\/DoseMeApp\/","article_published_time":"2018-12-03T18:15:28+00:00","article_modified_time":"2021-04-06T05:46:18+00:00","og_image":[{"width":1120,"height":630,"url":"https:\/\/doseme-rx.com\/wp-content\/uploads\/2018\/12\/News-Article-Banners.png","type":"image\/png"}],"author":"Nicola Hunter","twitter_card":"summary_large_image","twitter_creator":"@DoseMeApp","twitter_site":"@DoseMeApp","twitter_misc":{"\u00c9crit par":"Nicola Hunter","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/doseme-rx.com\/fr\/news-media\/articles\/doseme-tabula-rasa-healthcare#article","isPartOf":{"@id":"https:\/\/doseme-rx.com\/fr\/news-media\/articles\/doseme-tabula-rasa-healthcare"},"author":{"name":"Nicola Hunter","@id":"https:\/\/doseme-rx.com\/fr#\/schema\/person\/6c6769e1f0b02564d00c6693857210d9"},"headline":"Tabula Rasa HealthCare to Acquire DoseMe","datePublished":"2018-12-03T18:15:28+00:00","dateModified":"2021-04-06T05:46:18+00:00","mainEntityOfPage":{"@id":"https:\/\/doseme-rx.com\/fr\/news-media\/articles\/doseme-tabula-rasa-healthcare"},"wordCount":331,"commentCount":0,"image":{"@id":"https:\/\/doseme-rx.com\/fr\/news-media\/articles\/doseme-tabula-rasa-healthcare#primaryimage"},"thumbnailUrl":"https:\/\/doseme-rx.com\/wp-content\/uploads\/2018\/12\/News-Article-Banners.png","keywords":["Company Announcement"],"articleSection":["News & Media Centre"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/doseme-rx.com\/fr\/news-media\/articles\/doseme-tabula-rasa-healthcare#respond"]}]},{"@type":"WebPage","@id":"https:\/\/doseme-rx.com\/fr\/news-media\/articles\/doseme-tabula-rasa-healthcare","url":"https:\/\/doseme-rx.com\/fr\/news-media\/articles\/doseme-tabula-rasa-healthcare","name":"Tabula Rasa HealthCare To Aquire DoseMe","isPartOf":{"@id":"https:\/\/doseme-rx.com\/fr#website"},"primaryImageOfPage":{"@id":"https:\/\/doseme-rx.com\/fr\/news-media\/articles\/doseme-tabula-rasa-healthcare#primaryimage"},"image":{"@id":"https:\/\/doseme-rx.com\/fr\/news-media\/articles\/doseme-tabula-rasa-healthcare#primaryimage"},"thumbnailUrl":"https:\/\/doseme-rx.com\/wp-content\/uploads\/2018\/12\/News-Article-Banners.png","datePublished":"2018-12-03T18:15:28+00:00","dateModified":"2021-04-06T05:46:18+00:00","author":{"@id":"https:\/\/doseme-rx.com\/fr#\/schema\/person\/6c6769e1f0b02564d00c6693857210d9"},"description":"DoseMe, the first company in the world to design a precision dosing platform - DoseMeRx - specifically developed for clinical practice today announced it will be acquired by Tabula Rasa HealthCare, Inc (NASDAQ:TRHC) a healthcare technology company advancing the field of medication safety.","breadcrumb":{"@id":"https:\/\/doseme-rx.com\/fr\/news-media\/articles\/doseme-tabula-rasa-healthcare#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/doseme-rx.com\/fr\/news-media\/articles\/doseme-tabula-rasa-healthcare"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/doseme-rx.com\/fr\/news-media\/articles\/doseme-tabula-rasa-healthcare#primaryimage","url":"https:\/\/doseme-rx.com\/wp-content\/uploads\/2018\/12\/News-Article-Banners.png","contentUrl":"https:\/\/doseme-rx.com\/wp-content\/uploads\/2018\/12\/News-Article-Banners.png","width":1120,"height":630},{"@type":"BreadcrumbList","@id":"https:\/\/doseme-rx.com\/fr\/news-media\/articles\/doseme-tabula-rasa-healthcare#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/doseme-rx.com\/fr"},{"@type":"ListItem","position":2,"name":"Tabula Rasa HealthCare to Acquire DoseMe"}]},{"@type":"WebSite","@id":"https:\/\/doseme-rx.com\/fr#website","url":"https:\/\/doseme-rx.com\/fr","name":"DoseMeRx","description":"Choose us for our world-leading Bayesian dosing software. Stay with us for our best-in-class customer service.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/doseme-rx.com\/fr?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/doseme-rx.com\/fr#\/schema\/person\/6c6769e1f0b02564d00c6693857210d9","name":"Nicola Hunter","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/02e206174499150c025ce2682b2ee353f284349ff867886a3f957d50c95af6fe?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/02e206174499150c025ce2682b2ee353f284349ff867886a3f957d50c95af6fe?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/02e206174499150c025ce2682b2ee353f284349ff867886a3f957d50c95af6fe?s=96&d=mm&r=g","caption":"Nicola Hunter"},"url":"https:\/\/doseme-rx.com\/fr\/author\/nicola-hunter"}]}},"_links":{"self":[{"href":"https:\/\/doseme-rx.com\/fr\/wp-json\/wp\/v2\/posts\/3425","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/doseme-rx.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/doseme-rx.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/doseme-rx.com\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/doseme-rx.com\/fr\/wp-json\/wp\/v2\/comments?post=3425"}],"version-history":[{"count":6,"href":"https:\/\/doseme-rx.com\/fr\/wp-json\/wp\/v2\/posts\/3425\/revisions"}],"predecessor-version":[{"id":8371,"href":"https:\/\/doseme-rx.com\/fr\/wp-json\/wp\/v2\/posts\/3425\/revisions\/8371"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/doseme-rx.com\/fr\/wp-json\/wp\/v2\/media\/7998"}],"wp:attachment":[{"href":"https:\/\/doseme-rx.com\/fr\/wp-json\/wp\/v2\/media?parent=3425"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/doseme-rx.com\/fr\/wp-json\/wp\/v2\/categories?post=3425"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/doseme-rx.com\/fr\/wp-json\/wp\/v2\/tags?post=3425"},{"taxonomy":"article-type","embeddable":true,"href":"https:\/\/doseme-rx.com\/fr\/wp-json\/wp\/v2\/article-type?post=3425"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}